Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-041811
Filing Date
2017-06-26
Accepted
2017-06-26 13:56:22
Documents
1
Period of Report
2017-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4021
  Complete submission text file 0001209191-17-041811.txt   5398
Mailing Address 10555 SCIENCE CENTER DR SAN DIEGO CA 92121
Business Address
POPS RICHARD F (Reporting) CIK: 0001126490 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-35945 | Film No.: 17929423

Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Issuer) CIK: 0001571498 (see all company filings)

EIN.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations